Particularly, among all the NSCLC cell lines, the elevated expression levels of POU6F2-AS2 were considerably more pronounced in the H460 cell line, which was selected for the subsequent loss-of-function experiments. The gene discussed is POU6F2; the disease is non-small cell lung carcinoma.